HitGen Inc

688222

Company Profile

  • Business description

    HitGen Inc is engaged in drug research and development and provision of technical consultation, technology transfer, and technical services. The company uses DEL technology to provide research and development services for early drug discovery and transfer of new drug R&D projects.

  • Contact

    No. 18, Section 2, Biocity Middle Road
    Chengdu Tianfu International Biological City
    Shuangliu District, Sichuan Province
    Chengdu610093
    CHN

    T: +86 2885197385

    https://www.hitgen.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2025

    Employees

    483

Stocks News & Analysis

stocks

Going into earnings, is Netflix stock a buy, a sell, or fairly valued?

Watching sales growth and the potential for margin expansion, here’s what we think of Netflix stock.
stocks

Bapcor is paying for the sins of its past

Shares plunged over 17% after reporting disappointing results.
stocks

Overvalued ASX share as market underestimates downside risks

Growth outlook solid, but upside more than priced in.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,401.0027.300.29%
CAC 408,206.0731.870.39%
DAX 4024,258.80427.811.80%
Dow JONES (US)46,706.58515.971.12%
FTSE 1009,403.5749.000.52%
HKSE26,206.17347.341.34%
NASDAQ22,990.54310.571.37%
Nikkei 22549,835.43649.931.32%
NZX 50 Index13,334.0610.90-0.08%
S&P 5006,735.1371.121.07%
S&P/ASX 2009,103.0027.100.30%
SSE Composite Index3,879.9216.020.41%

Market Movers